Skip to content
10-K

Annual Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-12-000015

← back to feed
Filed
Aug 22, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Aug 8, 2012 111.55M sh
Operating Cash Flow FY 2012 · Jun 30, 2012 −$1.88M
Operating Cash Flow FY 2012 · Jun 30, 2010 −$125.08K
Net Income FY 2012 · Jun 30, 2012 −$1.85M
Operating Income FY 2012 · Jun 30, 2012 −$2.14M